Document is current
Any future updates will be listed below
-
Authors
Nakano, Takahiro
Dohi, Osamu https://orcid.org/0000-0002-0498-0144
Takagi, Tomohisa
Naito, Yuji
Fukui, Hayato
Miyazaki, Hajime
Yasuda, Takeshi
Yoshida, Takuma
Azuma, Yuka
Ishida, Tsugitaka
Kitae, Hiroaki
Matsumura, Shinya
Takayama, Shun
Mizuno, Naoki
Kashiwagi, Saori
Mizushima, Katsura
Inoue, Ryo
Doi, Toshifumi
Hirose, Ryohei
Inoue, Ken
Yoshida, Naohisa
Kamada, Kazuhiro
Uchiyama, Kazuhiko
Ishikawa, Takeshi
Konishi, Hideyuki
Itoh, Yoshito
-
Funding
Funding for this research was provided by:
Kaken Pharmaceutical (18K07916)
- License Information
-
More Information
Article History
Received: 24 December 2022
Accepted: 10 October 2023
First Online: 24 October 2023
Declarations
:
: Osamu Dohi received collaboration research funding from Fujifilm Co., Ltd. (J192001048, J192001259). Naohisa Yoshida received a research grant from Fujifilm Medical Co., Ltd. (J162001222). Yuji Naito received collaboration research funding from Fujifilm Medical Co., Ltd. (J132001115, J132001139). Yoshito Itoh was affiliated with a department that was partially funded by Fujifilm Medical Co., Ltd. (J082003006). The other authors declare no conflict of interest. Fujifilm Medical Co., Ltd. had no role in the design, conduct, data collection, data interpretation, or reporting of this study.
: The study was approved by the Clinical Ethics Committee on Human Experiments of Kyoto Prefectural University of Medicine (IRB Registration Number: ERB-C-979-1; October 19, 2017). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Written Informed consent to be included in the study, or the equivalent, was obtained from all patients. In addition, this study was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN000025702).
